Advertisement

Topics

Advent International Corporation Company Profile

12:09 EDT 24th September 2018 | BioPortfolio

Advent is one of the leading private equity investors in North America. Since 1985, we have invested more than $1.5bn in over 275 companies across the US and Canada and have helped over 75 of these companies achieve successful IPOs. We pursue buyouts, recapitalizations and growth equity investments in selected growth industries. Target sectors include: Buyout/Private Equity – business and financial services, retail and consumer, IT services and technology, healthcare services, and industrial Our North American team comprises over 25 investment professionals working from regional headquarters in Boston. Our managing directors and partners have an average of over 10 years' investment experience

Location

75 State Street
Boston
Massachusetts
02109
United States of America

Contact

Phone: 1 617 951 9400
Fax: 1 617 951 0566


News Articles [497 Associated News Articles listed on BioPortfolio]

M&As this week: Advent International, Eli Lilly

Advent International has entered an agreement to purchase Sanofi’s European generics business Zentiva for €1.9bn ($2.2bn). Advent intends to invest...Read More... The post M&As this week: Adv...

Sanofi to sell Zentiva generics arm to Advent

French drugmaker Sanofi announced on 17 April 2018 that it had entered into exclusive negotiations with Advent International (Advent) under which Advent would acquire Zentiva, Sanofi’s European gene...

Sanofi sells European generics business

Advent International and Sanofi have entered into exclusive negotiations under which Advent would acquire Zentiva, Sanofi's European generics business for €1,9 billion. Advent's offer is firm, bindi...

Sanofi Agrees to sell Generics to Advent

French drugmaker Sanofi and private equity investor Advent International have agreed a deal under which Advent will acquire Sanofi's European generics business Zentiva for €1.9 billion. Negot...

Advent In Talks To Buy Sanofi's European Generics Unit Zentiva For EUR 1.9 Bln

PARIS (dpa-AFX) - Advent International entered into exclusive negotiations to acquire Zentiva, Sanofi's (SNYNF, SNY) European generics business, for 1.9 billion euros. Advent's offer is firm, bind...

Sanofi, Advent finalize negotiations for acquisition of Zentiva

Sanofi and Advent International have completed negotiations for the acquisition of Zentiva, Sanofi’s European generics business, by Advent and the companies have signed a Share Purchase Agreement wo...

Advent in talks to buy Sanofi’s generics business for €1.9bn

French pharmaceutical giant Sanofi has entered into exclusive negotiations with US-based private equity firm Advent International to divest its European...Read More... The post Advent in talks to buy ...

Advent acquires Sanofi’s generics business for €1.9bn

US-based private equity firm Advent International has concluded negotiations and signed a share purchase agreement to acquire Sanofi’s generics business...Read More... The post Advent acquires Sanof...

PubMed Articles [577 Associated PubMed Articles listed on BioPortfolio]

Impact of Hajj on Global Health Security.

With the human society transfers from scattered pieces to a society as a whole and the advent of the aviation era, the occurrence of infectious diseases and their diffusion have led to international h...

Toward individual glomerular phenotyping: advent of precision medicine in kidney biopsies.

The road to precision medicine for nephrology is approaching quickly. In the present volume, the glomerular proteome has now been characterized at a single glomerulus level in mouse and human kidneys....

Advent of CRISPR Based Immunotherapy in Hematologic Malignancies.

Characteristics and outcomes of laparoscopic surgery in patients with large hiatal hernia. A single center study.

Giant hiatal hernia is characterized by the presence of more than 1/3 of the stomach in the chest, through the diaphragmatic hiatus, with or without other intra-abdominal organs. It is a rare patholog...

Delivery mode choice adds to complexity of counselling for spina bifida.

The management of fetal spina bifida used to be relatively straight-forward. An uncommon condition with a high termination rate in many other countries, the prenatal management for those continuing pr...

Clinical Trials [1081 Associated Clinical Trials listed on BioPortfolio]

Advent™ Cervical Disc Versus Anterior Cervical Discectomy and Fusion(ACDF) for Treatment of One Level Degenerative Disc Disease (IDE Study)

The purpose of this study is to establish the safety and effectiveness of the Advent™ Cervical Disc compared to Anterior Cervical Discectomy and Fusion (ACDF) in treating degenerative di...

Epidogs International Inventory of Seizure Alert Dogs

This international research project looks at the reliability of canine seizure alerting behaviour in epilepsy patients. In the first stage an international database to identify the size an...

International AGD Database; Determinants of AGD and Establishment of Normative Data

Aim: To collate data on Anogenital Distance (AGD) from several population studies to build an international database for Anogenital Distance (AGD) Primary objective: To build a database p...

Cohort of STEMI Patients

Ischemic heart disease is the leading cause of mortality in industrialized countries. ST elevated acute myocardial infarction is one of its most frequent and deadly manifestation. In the l...

International Study on NoSocomial Pneumonia in Intensive CaRE

The International study on NoSocomial Pneumonia in Intensive CaRE (PneumoINSPIRE) is a prospective, international, multicentre, observational, cohort study. The study aims to provide up-to...

Companies [1470 Associated Companies listed on BioPortfolio]

Advent Consumer Healthcare, LLC

Advent Consumer Healthcare, LLC is dedicated to delivering innovative consumer products to help physicians and healthcare providers increase a patient’s overall awareness, in...

Advent Venture Partners

Advent Venture Partners is one of the most experienced technology venture capital firms in the UK. Established in 1981 it invests in both the Information and Communications Technology and Life Science...

Advent International Corporation

Advent is one of the leading private equity investors in North America. Since 1985, we have invested more than $1.5bn in over 275 companies across the US and Canada and have helped over 75 of these co...

Service Corporation International

Service Corporation International (NYSE: SCI), headquartered in Houston, Texas, is North America’s leading provider of deathcare products and services. At June 30, 2010, we o...

SPORTFIVE Int. Ltd.

Established in 2001, SPORTFIVE has quickly become the benchmark in sports rights marketing. Major shareholders include the private equity company Advent International, the media conglomerate RTL Group...

More Information about "Advent International Corporation" on BioPortfolio

We have published hundreds of Advent International Corporation news stories on BioPortfolio along with dozens of Advent International Corporation Clinical Trials and PubMed Articles about Advent International Corporation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Advent International Corporation Companies in our database. You can also find out about relevant Advent International Corporation Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...


Corporate Database Quicklinks



Searches Linking to this Company Record